Smart Inhalers Market – Overview
The use of smart technology has established a
smart presence in the healthcare domain. This has led to an increased number of
smart devices. Market focused reports linked with the healthcare
industry among others recently have been made available by Market Research
Future which issues reports on this industry. The smart inhalers market share is projected to expand with a 23.50% CAGR approximately while
earning revenues worth USD 2.00 billion by the end of the forecast period 2032.
The need to monitor medicine dosage and schedule the medicine
intake in the market for smart inhalers has grown considerably. Due to the
prevalence of ailments like asthma, the market has grown considerably over the past few years. As asthma patients are
required to monitor their drug intake diligently,
the smart inhalers provide a great degree of convenience in that regard. The
development of the market is also powered
by the incorporation of cutting-edge technologies in these products.
Global
Competitive Analysis
The impetus for the market’s growth has altered the
competitive background of the market. By
ensuring supply and demand are in balance the competitors can unlock new
opportunities for growth. The key players and trends have created a positive
tone for development. The important trends and players have established a
positive tone for development. The opportunities for growth and innovation have
increased at a rapid pace transforming the landscape of the market. Engaging
and converting prospective opportunities is modifying the growth pace of the
market considerably. The competitors in the market have been spurred to devise
strategic road-maps that capitalize on the positive market cues.
Smart inhalers market
players are AstraZeneca, Gecko Health Innovations Inc., Cohero Health,
Adherium, GlaxoSmithKline, Inspiro Medical, and Propeller
Health.
Industry
Segments
The smart inhalers market outlook has been segmented on
the basis of application, type, end user, and region. On the basis of type,
the segment involves metered dose inhaler and dry powder inhaler. The
dry powder inhalers control the principal share of the market. The application
basis of segmentation of the market consists of asthma, COPD, and others. The
end user segmentation of the market is segmented
into respiratory care center, hospitals
& clinics, and others. On the basis of
regions, the market includes North America, APAC, Europe and rest of the world.
Detailed
Regional Analysis
The smart inhalers market
insights comprises regions such as North America, Middle East, Europe, Africa,
APAC and rest of the world. Globally,
the North American region is the major market for smart inhalers which is
predicted to touch $888.4 million in revenues approximately by 2023. The
European region was the second biggest market in 2016 which is worth $57.4
million. Additionally, the Asia Pacific market is anticipated to be the most
rapidly growing market and is likely to develop at a CAGR of 55.3 percent
during the forecast period from 2016 to 2022. The smart inhalers market in the
rest of world is anticipated to surge after 2019.
Market Research Future (MRFR), enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
United States of America
No comments:
Post a Comment